Trial Profile
The Efficacy of Eszopiclone 3 mg as Adjunctive Therapy in Subjects With Insomnia Related to Generalized Anxiety Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary) ; Escitalopram
- Indications Generalised anxiety disorder; Insomnia
- Focus Therapeutic Use
- Sponsors Sunovion Pharmaceuticals
- 30 Jul 2008 New trial record.